Lidocaine Hydrochloride Topical Solution USP 4% — Class I drug recall D-0280-2022
Terminated recall by Teligent Pharma, Inc., reported 2021-12-22, distributed nationwide. Superpotent Drug
| Recall number | D-0280-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-10-12 |
| Classified | 2021-12-13 |
| Reported by FDA | 2021-12-22 |
| Terminated | 2024-06-18 |
| Distributed | Nationwide (US) |
| Quantity | 52,104 glass |
| Reason classes | potency |
| NDC | 52565-0009-50 |
| Lot numbers | 13262, 14217 |
| Expiration dates | 2022-03, 2022-08 |
Product
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Reason for recall
Superpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0280-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.